Krishna Institute of Medical Sciences Limited has informed the Exchange regarding a press release dated August 06, 2025, titled "Press Release on Q1FY26".
KIMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
KIMS Hospitals reported Q1 FY26 consolidated revenue of INR 879 Cr, up 26.8% year-on-year and 9.6% quarter-on-quarter, driven by strong patient volume growth (IP volume +15.3% YoY, OP volume +19.3% YoY) and higher ARPOB (+11.8% YoY). However, profitability came under pressure: EBITDA margin contracted sharply to 22.7% from 26.6% in Q1 FY25, PAT fell to INR 85 Cr (from INR 95 Cr YoY and INR 106 Cr QoQ), and consolidated EPS declined 9.2% YoY to INR 1.96. Cash and equivalents stood at INR 70 Cr. Management remains optimistic about meeting FY26 targets and confirmed that two new Bangalore units are set to commence in Q2 FY26.
Mixed quarter for shareholders — strong topline growth and healthy operational metrics are offset by notable margin compression and a YoY decline in profits and EPS, which may pressure the stock in the short term despite positive volume trends and upcoming capacity expansion in Bangalore.